Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials
Clinical trial NCT05335876 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05335876
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-19
- Primary completion
- 2031-04-29
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.